Veeva Systems (VEEV) Gains As Market Dips: What You Should Know

Zacks
28 Jan

The latest trading session saw Veeva Systems (VEEV) ending at $225.77, denoting a +1.06% adjustment from its last day's close. This move outpaced the S&P 500's daily loss of 1.46%. Meanwhile, the Dow experienced a rise of 0.65%, and the technology-dominated Nasdaq saw a decrease of 3.07%.

The provider of cloud-based software services for the life sciences industry's shares have seen an increase of 4.39% over the last month, surpassing the Medical sector's gain of 1.84% and the S&P 500's gain of 1.08%.

Analysts and investors alike will be keeping a close eye on the performance of Veeva Systems in its upcoming earnings disclosure. It is anticipated that the company will report an EPS of $1.58, marking a 14.49% rise compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $698.28 million, indicating a 10.73% growth compared to the corresponding quarter of the prior year.

For the annual period, the Zacks Consensus Estimates anticipate earnings of $6.45 per share and a revenue of $2.72 billion, signifying shifts of +33.26% and +15.24%, respectively, from the last year.

Investors should also pay attention to any latest changes in analyst estimates for Veeva Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.

The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.44% higher. As of now, Veeva Systems holds a Zacks Rank of #3 (Hold).

With respect to valuation, Veeva Systems is currently being traded at a Forward P/E ratio of 34.62. This expresses no noticeable deviation compared to the average Forward P/E of 34.62 of its industry.

Meanwhile, VEEV's PEG ratio is currently 1.32. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As the market closed yesterday, the Medical Info Systems industry was having an average PEG ratio of 3.36.

The Medical Info Systems industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 56, placing it within the top 23% of over 250 industries.

The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Veeva Systems Inc. (VEEV) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10